Canlyniadau Chwilio - IMPACT Study Collaborators

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants gan Alexander Dias, Mark N. Brook, Elizabeth K. Bancroft, Elizabeth C. Page, Anthony Chamberlain, Sibel Saya, Jan Amin, Christos Mikropoulos, Natalie Taylor, Kathryn Myhill, Sarah Thomas, Edward Saunders, Tokhir Dadaev, Daniel Leongamornlert, Thomas Dyrsø Jensen, D. Gareth Evans, Cezary Cybulski, Annelie Liljegren, Soo H. Teo, Lucy Side, The IMPACT study collaborators and Steering Committee, Zsofia Kote‐Jarai, Rosalind A. Eeles

Cael y testun llawn

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. gan Hayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, Anne Y Warren, Johanna Burge, Anne George, Elizabeth Bancroft, Sameer Jhavar, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Edward Saunders, Elizabeth Page, Anita Mitra, Gillian Mitchell, Geoffrey J Lindeman, D Gareth Evans, Ignacio Blanco, Catherine Mercer, Wendy S Rubinstein, Virginia Clowes, Fiona Douglas, Shirley Hodgson, Lisa Walker, Alan Donaldson, Louise Izatt, Huw Dorkins, Alison Male, Kathy Tucker, Alan Stapleton, Jimmy Lam, Judy Kirk, Hans Lilja, Douglas Easton, IMPACT Study Steering Committee, IMPACT Study Collaborators, UK GPCS Collaborators, Colin Cooper, Rosalind Eeles, David E Neal

Cael y testun llawn